Cheng Gang was fed up with this inexplicable sense of superiority from foreign companies.
He chose to return to China after graduating from Americen as a doctor because the hidden ceiling for Chinese in Americen was too thick and difficult to break.
Therefore, Cheng Gang has never had a good impression of European and American companies.
This time the public's inexplicable sense of superiority made him even more unhappy.
In the end, I couldn't help but retort a few words.
The other party obviously did not expect Cheng Gang's reaction, and the two parties broke up unhappy.
Volkswagen's influence in the country is huge.
The upstream and downstream industrial chains of the joint venture companies SAIC-Volkswagen and FAW-Volkswagen have jointly affected more than 200,000 jobs.
(Estimated based on the number of Volkswagen employees at FAW-Volkswagen’s North China base.)
Not to mention that this year happens to be the 30th anniversary of Volkswagen entering the Chinese market, and it has been operating in the Chinese political and business circles for 30 years.
Soon Kechuang Biotech came under pressure from Chinese officials.
Tesla's energy is far inferior to that of Volkswagen.
As a mature manager, Cheng Gang would not let his emotions affect his normal work. He immediately reported the situation to Zheng Li:
"A certain domestic department told me that it hopes we can treat foreign companies and domestic car companies equally."
(I can only express it implicitly here. In fact, Cheng Gang's remarks must be very straightforward, otherwise Zheng Li, an alien, would not be able to understand the twists and turns)
After Cheng Gang finished explaining in detail, Zheng Li said in confusion:
"Don't BYD supply to SAIC and FAW's wholly-owned electric vehicle brands?"
Cheng Gang said helplessly: "Yes, but the sales of the joint venture's new energy vehicle brands have been seriously affected."
Zheng Li continued to ask: "Now that China's electric vehicle brands have technological advantages, isn't this an opportunity to overtake in corners?"
"It's not that we don't supply foreign manufacturers, but the production cycle of graphene manufacturing machines is so long. Is there no problem in giving priority to domestic companies?"
Cheng Gang nodded: "No problem."
"But not everyone thinks that way."
"The above stated that we refuse to provide super lithium battery technology to Tesla. They completely understand and support it."
“But we cannot treat foreign manufacturers that we have cooperated with for many years differently.”
"If the production capacity of Kechuang Biotech is insufficient, the graphene multi-layer structure manufacturing technology can also be patented."
Cheng Gang seemed to have something to say. After a moment of pause, he decided to talk to Zheng Li:
"Director Zheng, in fact, the higher-ups may not really want to help the public obtain technology authorization as simple as this."
"Some people have told me through various channels that the proportion of state-owned assets in Kechuang Biotechnology is too low. This incident is actually a different kind of warning."
Kechuang Biotech gave BOCOM International 5% of its shares during its Series B investment.
After listing, 10% of the shares were publicly issued.
Even if China's state-owned capital acquires all these shares, it will only amount to 15%.
It is obviously not enough for such an important company as Kechuang Biotechnology.
"I think you must have heard the news in the Lion City."
Zheng Li sighed: "Okay, got it."
“Can other state-owned brands stop this?”
Cheng Gang shook his head: "OEMs are undoubtedly the winners in this matter, but the official influence of new car-making forces such as Weilai, Xiaopeng, and Ideal is too low."
"The most they can say is make suggestions, but they don't have much effect."
"And the battery factory actually slanders us."
"If they don't lock orders to domestic car companies in advance, they can simply raise prices and supply on demand. The one with the highest price will win."
"You can get the biggest part of the profits."
"But now the order has been signed before the production of super lithium batteries. In this market where supply is far less than demand and the relationship between supply and demand is abnormal, they cannot obtain excess benefits."
"So there's no party that can really help us take the pressure off of this."
Zheng Li nodded: "Okay, you go and contact us, we can appropriately increase the shares to resolve this matter."
In a sense, Zheng Li still wants the current vest and wants to play within the rules, so he can only do this.
Because even if this compromise is made, battery manufacturers will be allowed to play freely.
Then the technology alliance built by Kechuang Biotechnology is useless. The leader of the alliance is so easy to compromise. Where is your right to speak?
In addition, appropriately releasing shares to state-owned assets can, in a sense, be done once and for all.
Similar incidents will not happen again in the future.
Zheng Li's bottom line is that he must maintain at least 51% of the shares and have control.
Absolute control has long been lost.
Cheng Gang saw that Zheng Li didn't look good, so he comforted him: "Director Zheng, people must learn to compromise when it's time to compromise."
"Appropriately increasing the proportion of state-owned assets is a good thing. We can get more support from the official level."
"In addition, you can also cash out part of your shares, start a new venture in the Lion City, or set up an offshore trust fund."
"It is not necessary to increase the share capital, but you can also transfer the shares. Even if you only transfer 5% of the shares to the state-owned assets, using this part of the money to establish a trust is enough to ensure the prosperity of future generations for two hundred years."
Many wealthy people in China like to go to Xiangjiang to set up trusts.
Many top-level wealthy people in Shenhai go to Xiangjiang to set up trusts, while ordinary middle-class people go to Xiangjiang to buy commercial pension insurance.
"Announcement of Kechuang Biotechnology Co., Ltd. on the progress of planned share transfer changes and suspension of trading"
"LI ZHEN, the controlling shareholder and actual controller of Kechuang Biotech Co., Ltd. (hereinafter referred to as "Kechuang Biotech")
(Zheng Li) (Chairman) Recent planning shares
Transfer matters. Transactions via the company to Shenhai Securities
As applied for, the company’s stock (stock abbreviation: Kechuang Biotech, stock code: ******) will be issued on January 31, 2024
Trading will be suspended from the market opening on the morning of Wednesday (Wednesday)..."
Kechuang Biotechnology suspended trading, and the private transfer of non-tradable restricted shares by its major shareholders caused an uproar in the investment circle.
Because the stock price of Kechuang Biotech has been rising steadily, especially since the brain-computer connected VR has received an enthusiastic response after its launch, Zheng Li has no reason to transfer the company.
"There won't be any thunderstorms at Kechuang Biotechnology, right?"
"I'm overthinking it. For such an expensive company, how could the transferee not do due diligence when transferring shares?"
"Maybe Zheng Shen just wants to cash out part of it. Non-tradable shares are not easy to be listed and traded, so he can only use this method."
"As long as Zheng Shen is still the chairman of Kechuang Biotech, I will always hold shares in Kechuang Biotech."
"Let's wait and see the annual report. The transferee has not yet come out. The transferee may be able to help the development of Science and Technology Biotechnology in some aspects."
The stock bar of Kechuang Biotech is very lively. As the company with the highest market value among listed companies in China, the stock bar of Kechuang Biotech has always been very lively.
It's just the sudden announcement that makes the place even more lively.
Investors are still guessing, and investment institutions have already gotten the news.
When it comes to such a large market and such high capital flows, it is obvious that top investment institutions cannot hide it.
"I really didn't expect that Zheng Li would transfer his shares at this time. Not everyone has the courage to transfer his shares during the rising period."
"Zheng Li is not an ordinary person. I just regret that we are not the transferee. In such a good company as Kechuang Biotech, we only hold 5% of the shares."
"There is no way. The transferee is China Investment. What can we do to fight with them in China?"
Huaguo Investment Co., Ltd. had a registered capital of 200 billion yuan when it was established in 2007.
One of the world's largest sovereign wealth funds, known for its deep pockets.
(The chairman of my former employer later went to Huaguo Investment Group to become the chairman)
"We can only regret that we did not expect that Zheng Li would be willing to sell shares at this time. We might have a chance to talk to Zheng Li in advance."
"Then have you ever thought that Huaguo Investment Co., Ltd. has used chips that we cannot use?"
"Transaction money of this level is secondary. It may indeed be a bargaining chip that we cannot afford. Kechuang Biotechnology's position is now more stable."
"And you regret that we are not the transferee this time, so this opportunity is not something we can seize.
It would be better to regret that when Kechuang Biotech participated in Series B venture capital investment, we only obtained 5% of the shares.
It would have been great if I had taken 10% of the shares at that time. "
Also indirectly affected was Li Shuyao. She called Li Miaomiao after get off work at 10pm:
"Miaomiao, it's too difficult. Why did Zheng Li suddenly transfer his shares?"
After Li Miaomiao turned on the outside, he said while washing: "The company needs to develop, so the shares are transferred."
Li Shuyao asked: "Then do you know who the transferee is?"
"The leader asked me to write a research report on the transfer of shares by Kechuang Biotech's controlling shareholder. It also needs to be written with distinctive features."
"The problem is that there are so many research reports on scientific and innovative biology, how can we write something unique?"
"There is only one announcement now. The transferee, share transfer share and price are not known at all."
"Under such circumstances, it is really difficult for me to have new ideas when writing a research report."
"Sometimes when leaders make some requests, you wonder if they are living in outer space. They are not grounded at all."
After Li Shuyao finished complaining, Li Miaomiao said slowly:
"The transferee is also a state-owned enterprise prefixed with Chinese. I guess your leaders must have gotten the news. This is a test for you."
Li Shuyao suddenly realized: "The prefix starts with Zhong? It can't be CICC, right?"
"Probably not. If it was CICC, with this level of positive news, the gods who got the news should have pulled CICC out of a high-volume positive line."
Li Miaomiao went through the process in his mind but didn't come up with it. There were too many state-owned enterprises and many of them were powerful.
She really couldn't guess which one it was: "It shouldn't be a listed state-owned enterprise with a Chinese prefix, it should be a wholly-owned state-owned enterprise."
"No wonder, I know how to write a research report."
"Let's start with the diversification of shareholder composition and the good expectations that Huaguo officials are optimistic about the future development prospects of Kechuang Biotechnology."
"Written around the further improvement of the strategic status of Science and Technology Biotechnology."
Just add a name, and then replace it with one click when the specific announcement comes out.
The most important thing is that the research report must be issued as soon as possible and written in a realistic manner. Brokerage research reports have also been very busy in recent years.
If it wasn't too complicated, there wouldn't be any securities firm researchers who would use the Five Elements attributes to interpret Big A.
But Big A is indeed metaphysics.
Li Miaomiao smiled and said: "Haha, the way you write research reports skillfully makes me feel bad."
Li Shuyao smiled bitterly: "This is what hard-working investment bankers are like. Writing and reading research reports are basic skills."
Veteran investment bankers know exactly how much a research report contains, which ones are copied and pasted, and which brokerage firms’ research reports actually contain valuable information.
Li Shuyao asked: "Did you come back from the Lion City a few days ago? How many more days did you have with Zheng Li?"
Li Miaomiao has become accustomed to Li Shuyao's teasing: "There are things at work that require Zheng Li's signature and fingerprints."
Li Shuyao seemed to have remembered something and asked: "Zheng Shen, have you considered how to handle the money from this share transfer?"
"Can you put a small part of it into CICC? Although CICC's wealth management scale is not large, it is small but sophisticated."
"If Zheng Shen has this intention, I will switch to the front end overnight. A small goal will be enough for me for ten years."
Li Miaomiao: "This is not something I can decide. Zheng Li must have his own plans."
"I didn't ask."
Li Shuyao was curious: "What do you usually talk about when you meet? Or do you talk about work?"
Li Miaomiao thought for a moment and then replied: "Most of the time we talk about work, and occasionally we talk about other things."
Li Shuyao: "What a boring person~"
...
In a secret laboratory in America, research on Bill has been ongoing.
“On a physical level, Bill is indeed lacking something in his body.
There are still reward hormones and intimacy hormones in his body.
But he really couldn't feel any positive emotions.
The psychiatrist's intervention to regulate his emotions was ineffective.
The lack of neurotransmitters in his body caused the GABAergic neuron mechanism to not function properly.
Including dopamine-releasing SWELL1 channels in astrocytes that regulate synaptic transmission cannot proceed normally..."
"Of course I know that psychiatrists can't help. The big shots have hired so many psychiatrists, but it has no effect at all. Please tell me the conclusion directly."
"Based on the current results, a simple loss of neurotransmitters may only be part of the cause of Bill's condition.
We suspect that Bill has a soul defect, which means that Merlin's attack is not only physical, but also spiritual. "
"Okay, I know you have no evidence when it comes to the soul level, and it's impossible to kill Bill with just one shot.
I don’t expect reverse technology to be cracked in the short term. The project will continue to advance until there is progress.
Write the report above based on the actual situation, and don't give the big shots too high expectations.
Otherwise, if we fail to meet their expectations, we will all be screwed.
Lower their expectations. "
"Okay. In addition, according to the investigation results of William's corpse, his brain structure has undergone major changes from the normal brain structure, and it is also different from the internal structure of Witten's brain.
We speculate that the magic brain Merlin injected into William was a brand new model. "
"It's normal. Merlin has different types of magic brains in his hands. We have already expected it.
In a sense, this is a genetic medicine, and it is normal to have a wide variety of medicines. "
"There is also no progress in the reverse engineering of the Demonic Brain, and there is currently no idea."
"I can totally understand that magic is indeed something beyond our understanding."
After Amerikan and the European Union jointly conducted an examination of William's body, both parties found no valuable findings.
All that can be confirmed is that William was controlled remotely by Merlin, and the control method is only speculation.
The wand obtained by the Europa Alliance, after letting Pierre hold it for experiments, they found that it also had no effect on increasing mana.
